dr. motzer on a phase ii trial of nivolumab for mrcc
Published 9 years ago • 226 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
5:50
phase ii trial on nivolumab in mrcc - dr. robert motzer at asco 2014
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
1:25
dr. motzer discusses nivolumab for mrcc
-
1:57
dr. motzer on nivolumab versus everolimus in renal call carcinoma
-
1:32
dr. voss on phase i/ii trial data of medi0680/durvalumab versus nivolumab in mrcc
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
4:43
nivolumab in renal cell carcinoma
-
6:52
nivolumab in renal cell carcinoma
-
1:24
dr. motzer on the tivo-1 trial with tivozanib in advanced rcc
-
10:22
dr. karasic on phase ii trial of nivolumab and ipilimumab
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:11
dr. motzer on the milestone of immunotherapy in rcc
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
1:56
dr. robert motzer reviews the phase iii comparz study
-
4:05
long-term rcc data with nivolumab
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
0:43
dr. pal on sequencing nivolumab in rcc
-
1:23
dr. lee on immunotherapy's future in rcc
-
1:18
dr. joel neal on impact of pd-l1 tests on pembrolizumab, nivolumab efficacy in frontline nsclc